|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002962,
umls-concept:C0008976,
umls-concept:C0014257,
umls-concept:C0017296,
umls-concept:C0018270,
umls-concept:C0030705,
umls-concept:C0032136,
umls-concept:C0034656,
umls-concept:C0205082,
umls-concept:C0205360,
umls-concept:C0439851,
umls-concept:C0599724,
umls-concept:C1552596,
umls-concept:C1801960,
umls-concept:C1947931
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2005-4-5
|
|
pubmed:abstractText |
In the Euroinject One phase II randomized double-blind trial, therapeutic angiogenesis of percutaneous intramyocardial plasmid gene transfer of vascular endothelial growth factor (phVEGF-A(165)) on myocardial perfusion, left ventricular function, and clinical symptoms was assessed.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0735-1097
|
|
pubmed:author |
pubmed-author:BøtkerHans ErikHE,
pubmed-author:BlombergPontusP,
pubmed-author:DrvotaViktorV,
pubmed-author:DudekDariuszD,
pubmed-author:GlogarDietmarD,
pubmed-author:GyöngyösiMariannM,
pubmed-author:HesseBirgerB,
pubmed-author:JørgensenErikE,
pubmed-author:KastrupJensJ,
pubmed-author:RuzylloWitoldW,
pubmed-author:SylvénChristerC,
pubmed-author:TägilKristinaK,
pubmed-author:ThuesenLeifL,
pubmed-author:WackAndreasA,
pubmed-author:YUANH HHH
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
5
|
|
pubmed:volume |
45
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
982-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15808751-Angina Pectoris,
pubmed-meshheading:15808751-Double-Blind Method,
pubmed-meshheading:15808751-Europe,
pubmed-meshheading:15808751-Exercise Test,
pubmed-meshheading:15808751-Female,
pubmed-meshheading:15808751-Gene Therapy,
pubmed-meshheading:15808751-Humans,
pubmed-meshheading:15808751-Male,
pubmed-meshheading:15808751-Middle Aged,
pubmed-meshheading:15808751-Neovascularization, Pathologic,
pubmed-meshheading:15808751-Plasmids,
pubmed-meshheading:15808751-Radiopharmaceuticals,
pubmed-meshheading:15808751-Severity of Illness Index,
pubmed-meshheading:15808751-Technetium Tc 99m Sestamibi,
pubmed-meshheading:15808751-Tomography, Emission-Computed, Single-Photon,
pubmed-meshheading:15808751-Treatment Outcome,
pubmed-meshheading:15808751-Vascular Endothelial Growth Factor A,
pubmed-meshheading:15808751-Ventricular Dysfunction, Left
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial.
|
|
pubmed:affiliation |
Cardiac Catheterization Laboratory, University Hospital Rigshospitalet, Copenhagen, Denmark.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II
|
